Vertex To Present At Upcoming Investor Conferences

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it will present at the Credit Suisse Healthcare Conference in Scottsdale, AZ on Tuesday, November 12 at 1:30 p.m. ET. Vertex will also present at the Deutsche Bank BioFEST in Boston, MA on December 2 at 2:50 p.m. ET.

The audio portion of the remarks from both conferences will be accessible live through Vertex’s website at in the “Investors” section under the “Events and Presentations” link. A replay of the conference call and webcast will be archived on the company’s website for a period of seven days after the presentations.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of cystic fibrosis, hepatitis C, rheumatoid arthritis and other life-threatening diseases. In addition to our clinical development programs, Vertex has more than a dozen ongoing preclinical programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For four years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit


Copyright Business Wire 2010